This document provides the framework to support the provision of renal replacement therapy (RRT) during an escalating pandemic. It should be used to inform local policies and procedures, which should be current and reviewed regularly.
Renal replacement therapy (RRT) is used to treat adult patients with acute kidney injury (AKI) in the intensive care unit (ICU). In NSW there are an estimated 169 machines that are capable of providing renal replacement therapy. Level 5 and 6 ICUs have the capacity to provide continuous renal replacement therapy (CRRT). Some ICUs also have the ability to provide intermittent renal replacement therapy (IRRT), intermittent haemodialysis (IHD) or sustained low efficiency dialysis (SLED). There are another 277 machines in outpatient dialysis units in NSW.
During the COVID-19 pandemic, there may be an increased need for patients requiring dialysis with AKI in the ICU. In this instance, state wide and local contingency plans should be in place to guide resource allocation and patient prioritisation for treatment.
[back to top]
In May 2020, a rapid evidence review was conducted by the COVID-19 Critical Intelligence Unit (Appendix 1). This document includes international evidence and data, as well as expert opinions. Senior clinicians, both medical and nursing from the NSW Intensive Care and Renal Communities of Practice, were consulted during the development of this document.
International data suggests that the prevalence of AKI in patients with COVID-19 is 3-9% and is more common in patients with severe disease, affecting up to 30% of critically ill patients in the ICU.1, 2, 3, 4 The need for renal dialysis usually arises during the second week of infection with COVID-19, with studies reporting up to 25% of patients in ICU required RRT. 5, 6
The indications for RRT for AKI in COVID-19 patients may result from hypovolaemia, haemodynamic changes, viral infection leading to kidney tubular injury, thrombotic vascular processes, glomerular pathology, rhabdomyolysis or fluid overload associated with respiratory failure.7 AKI is more common among patients with severe infection of COVID-19 and is considered a negative prognostic factor with respect to survival.
The option of which type of RRT used, CRRT or IHD, will depend on the patient’s clinical status and the ICU’s resources.8 ICUs in NSW vary in types of machines and modes of RRT provided. If the patient is haemodynamically-stable, consider IHD, if available, as the first option due to human resource and costefficiency. CRRT is preferable for more haemodynamically-unstable patients.
Complex ethical and clinical treatment issues can occur during a pandemic, especially when healthcare demand exceeds supply. It may be necessary at some point to begin prioritising limited critical care resources to those with a need for treatment and those who are most likely to survive. Such prioritisation decisions would need to take into account all patients’ probability of survival, as well as the availability of limited critical care resources.
Based on possible resource limitations, local health districts (LHDs) and facilities in NSW should plan and prepare by considering the following recommendations:
COVID-19 Critical Intelligence Unit – Evidence Check
This checklist is for use by renal unit senior management teams in Australia and Aotearoa New Zealand to assist in considering key components of COVID-19 contingency planning for their units and hospitals.
The checklist is for general information only and is not a list of mandatory requirements. It is recognised that each unit will have specific circumstances and challenges that will require local solutions. The topics in this checklist are intended to cover major themes that should be considered.
Please refer to the important notice at the end of the checklist.
This checklist has been developed by the Australian and New Zealand Society of Nephrologists (ANZSN) for the information of Australian and New Zealand renal units to support their COVID-19 contingency planning. It has had regard to materials developed by the Centers for Disease Control (CDC), USA, relating to dialysis facility preparedness.9
The original CDC materials are available free-of- charge on the CDC website. The use or publication of this checklist, including any links to the materials on the CDC website and any information or other content contained in this checklist, does not constitute or imply endorsement or recommendation by the CDC or the United States Government of this checklist or the information or other content therein, or the Australian and New Zealand Society of Nephrology (ANZSN), any of its officers, employees, agents or members, or any other person or organisation that uses or publishes this checklist.
The COVID-19 pandemic is rapidly evolving and there is currently limited information about the SARS-CoV-2 virus or COVID-19 disease aetiology or treatment. Application or use of this checklist is to be considered in this context.
The ANZSN has made reasonable efforts to ensure that the information in this checklist is as accurate as possible, however ANZSN does not in any way guarantee or warrant the accuracy, completeness, currency or source of any material in this checklist.
The ANZSN reserves the right to change any information in this checklist at any time.
This checklist is made available for general information purposes only and should in no way be a considered as specific medical or clinical advice nor as a substitute for professional advice and judgement provided by a healthcare service, healthcare professional or other subject matter expert in individual cases. Each health service or organisation operating a renal unit is responsible for ensuring and assuring its own COVID-19 preparedness.
ANZSN does not endorse, or warrant, or make any other representation whatsoever, or take any responsibility whatsoever for the relevant CDC materials to which it has had regard or any other CDC materials appearing on the CDC website.
The ANZSN accepts no liability for any loss or damage whatsoever suffered either directly or indirectly as a result of using or otherwise relying upon any material or information made available in this checklist, or in connection with the suitability, for any purpose, of the contents of this checklist.
This checklist may be accessed from other countries around the world and may contain references to products, services, and programs that have not been announced in your country. These references do not imply that ANZSN intends to announce such products, services or program in your country.
CRRT – continuous renal replacement therapy ICU – intensive care unit
IHD – intermittent haemodialysis PD - peritoneal dialysis
SLED - sustained low efficiency dialysis
RO – reverse osmosis.
Consulted with senior clinicians, both medical and nursing, from NSW intensive care units through the:
Dr Nigel Lyons, Deputy Secretary, Health System Strategy and Planning, NSW Ministry of Health.
Intensive care Clinical Director and Network Manager
To support adult intensive care and ward staff with surge in COVID-19 pandemic.